Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Verastem, Inc. (VSTM)

Pharmaceutical Preparations

https://www.verastem.com

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

117 KENDRICK STREET, SUITE 500
NEEDHAM, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/27/2012

Market Cap

92,359,292

Shares Outstanding

25,270,000

Weighted SO

25,268,102

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

VKTX --.--%

TRVN --.--%

KPTI --.--%

ACRX --.--%

INFI --.--%

Beta

0.1880

Last Div

0.0000

Range

2.1-14.22

Chg

-0.0350

Avg Vol

1076214

Mkt Cap

92359292

Exch

NASDAQ

Country

US

Phone

781 292 4200

DCF Diff

0.5847

DCF

1.6903

Div Yield

0.0000

P/S

9.1318

EV Multiple

-0.5279

P/FV

1.5408

Div Yield %

0.0000

P/E

-0.6889

PEG

-0.0509

Payout

0.0000

Current Ratio

3.2836

Quick Ratio

3.2836

Cash Ratio

2.7473

DSO

390.6590

DIO

0.0000

Op Cycle

390.6590

DPO

110794.0909

CCC

-110403.4319

Gross Margin

0.9978

Op Margin

-9.7671

Pretax Margin

-8.8482

Net Margin

-8.8482

Eff Tax Rate

-0.0634

ROA

-0.8463

ROE

-1.3302

ROCE

-1.3101

NI/EBT

1.0000

EBT/EBIT

0.9059

EBIT/Rev

-9.7671

Debt Ratio

0.3959

D/E

1.0463

LT Debt/Cap

0.4694

Total Debt/Cap

0.5113

Int Coverage

-44.0803

CF/Debt

-2.4400

Equity Multi

2.6430

Rec Turnover

0.9343

Pay Turnover

0.0033

Inv Turnover

0.0000

FA Turnover

11.7332

Asset Turnover

0.0956

OCF/Share

-3.8028

FCF/Share

-3.8036

Cash/Share

3.1038

OCF/Sales

-10.0996

FCF/OCF

1.0002

CF Coverage

-2.4400

ST Coverage

-15.7780

CapEx Coverage

-4864.1429

Div&CapEx Cov

-4864.1429

P/BV

1.5408

P/B

1.5408

P/S

9.1318

P/E

-0.6889

P/FCF

-0.9040

P/OCF

-0.6035

P/CF

-0.6035

PEG

-0.0509

P/S

9.1318

EV Multiple

-0.5279

P/FV

1.5408

DPS

0.0000

Latest Headlines (EST)

Benzinga Nov 15, 12:01 Where Verastem Stands With Analysts Seeking Alpha Nov 12, 01:40 Verastem: Potential Accelerated Approval Filing In H1 2024 Seeking Alpha Nov 12, 01:40 Verastem: Potential Accelerated Approval Filing In H1 2024 Seeking Alpha Nov 12, 01:40 Verastem: Potential Accelerated Approval Filing In H1 2024

Revenue Product Segmentation